Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action. | Sci Adv | 2024 | 39383229 | PubTator, text mining | PubMed |
| Molecular Pathology of Myotonic Dystrophy Type 1 in Iceland. | Mol Genet Genomic Med | 2024 | 39373365 | PubTator, text mining | PubMed |
| [Application of triplet-primer PCR technology for the genetic testing and prenatal diagnosis of patients with Myotonic dystrophy type 1]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39344611 | PubTator, text mining | PubMed |
| Online Age Verification: Government Legislation, Supplier Responsibilization, and Public Perceptions. | Children (Basel) | 2024 | 39334601 | PubTator, text mining | PubMed |
| CUG repeat RNA-dependent proteasomal degradation of MBNL1 in a cellular model of myotonic dystrophy type 1. | Biochem Biophys Res Commun | 2024 | 39326259 | PubTator, text mining | PubMed |
| Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells. | Stem Cell Res Ther | 2024 | 39278936 | PubTator, text mining | PubMed |
| Hypogammaglobulinemia and infection risk in myotonic dystrophy type 1. | Muscle Nerve | 2024 | 39267217 | PubTator, text mining | PubMed |
| SRSF2 is a key player in orchestrating the directional migration and differentiation of MyoD progenitors during skeletal muscle development. | Elife | 2024 | 39248331 | PubTator, text mining | PubMed |
| Clinical and genetic evaluation of hereditary myopathies in an adult Saudi cohort. | BMC Neurol | 2024 | 39232665 | PubTator, text mining | PubMed |
| Intellectual Profile in Myotonic Dystrophy Type 1 and Its Association With Its Onset: A Systematic Review and Meta-Analysis. | Pediatr Neurol | 2024 | 39232462 | PubTator, text mining | PubMed |
| Expression levels of core spliceosomal proteins modulate the MBNL-mediated spliceopathy in DM1. | Hum Mol Genet | 2024 | 39180495 | PubTator, text mining | PubMed |
| Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity. | J Med Chem | 2024 | 39080842 | PubTator, text mining | PubMed |
| Resolving the chromatin impact of mosaic variants with targeted Fiber-seq. | bioRxiv | 2024 | 39026856 | PubTator, text mining | PubMed |
| Meeting report: DMPK optimisation strategies and quantitative translational PKPD frameworks to predict human PK and efficacious dose of targeted protein degraders. | Xenobiotica | 2024 | 38934475 | PubTator, text mining | PubMed |
| Multiple Follicular Hybrid Tumors Presenting in Association With Myotonic Dystrophy Type 1. | Am J Dermatopathol | 2024 | 38916235 | PubTator, text mining | PubMed |
| Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2024 | 38836869 | PubTator, text mining | PubMed |
| Microbial diversity and metabolic pathways linked to benzene degradation in petrochemical-polluted groundwater. | Environ Int | 2024 | 38772206 | PubTator, text mining | PubMed |
| Primary amenorrhea in myotonic dystrophy type 1: Initial presentation versus incidental finding on whole genome sequencing. | Am J Med Genet A | 2024 | 38709060 | PubTator, text mining | PubMed |
| Generation of a lymphoblastoid-derived induced pluripotent stem cell line (CBRCULi015-A) from a patient with congenital myotonic dystrophy. | Stem Cell Res | 2024 | 38704930 | PubTator, text mining | PubMed |
| FEP Augmentation as a Means to Solve Data Paucity Problems for Machine Learning in Chemical Biology. | J Chem Inf Model | 2024 | 38651738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=8